Translational Development Acquisition Corp. (TDAC) Financial Ratios
4 years of historical data (2022–2025) · Financial Services · Shell Companies
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
1.06
+2% vs avg
5yr avg: 1.03
30Y Low1.0·High1.0
ROE
↑
3.7%
↓+105% vs avg
5yr avg: 1.8%
30Y Low-0%·High4%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
TDAC Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Translational Development Acquisition Corp. trades at 29.1x earnings, roughly in line with its 5-year average of 28.4x, sitting at the 100th percentile of its historical range. Compared to the Financial Services sector median P/E of 13.6x, the stock trades at a premium of 113%.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Market Cap | $236M | $181M | — | — | — |
| Enterprise Value | $236M | $181M | — | — | — |
| P/E Ratio → | 29.05 | 28.35 | — | — | — |
| P/S Ratio | — | — | — | — | — |
| P/B Ratio | 1.06 | 1.03 | — | — | — |
| P/FCF | — | — | — | — | — |
| P/OCF | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
TDAC EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — |
| EV / FCF | — | — | — | — | — |
TDAC Profitability
Margins and return-on-capital ratios measuring operating efficiency
ROE of 3.7% is modest, trailing the sector median of 9.0%.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Gross Margin | — | — | 69.9% | — | — |
| Operating Margin | — | — | -18.4% | — | — |
| Net Profit Margin | — | — | -6.7% | — | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| ROE | 3.7% | 3.7% | -0.1% | — | — |
| ROA | 3.6% | 3.6% | -0.1% | -221.1% | -16.2% |
| ROIC | -0.4% | -0.4% | -0.2% | -949.2% | — |
| ROCE | -0.5% | -0.5% | -0.2% | — | — |
TDAC Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $170213 ($200000 total debt minus $29787 cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | — | — |
| Debt / EBITDA | — | — | — | — | — |
| Net Debt / Equity | — | 0.00 | -0.00 | — | — |
| Net Debt / EBITDA | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — |
| Interest Coverage | — | — | -0.14 | — | — |
TDAC Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.07x is below 1.0, meaning current liabilities exceed current assets. The current ratio has improved from 0.00x to 0.07x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Current Ratio | 0.07 | 0.07 | 3.09 | 0.00 | 0.12 |
| Quick Ratio | 0.07 | 0.07 | 3.09 | 0.00 | 0.12 |
| Cash Ratio | 0.05 | 0.05 | 2.08 | 0.00 | 0.00 |
| Asset Turnover | — | — | 0.01 | — | — |
| Inventory Turnover | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — |
TDAC Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Translational Development Acquisition Corp. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 3.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Earnings Yield | 3.4% | 3.5% | — | — | — |
| FCF Yield | — | — | — | — | — |
| Buyback Yield | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | — | — | — | — |
| Shares Outstanding | — | $17M | $4M | $4M | $4M |
Peer Comparison
Compare TDAC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 TDACYou | $236M | 29.1 | — | — | — | — | 3.7% | -0.4% | — |
 NUVB | $2B | -9.6 | — | — | 86.6% | -338.7% | -53.2% | -54.3% | — |
 HCAI | $9M | -0.2 | — | — | 6.2% | -322.7% | -262.3% | -71.3% | — |
 GS | $351B | 21.6 | 33.1 | — | 47.5% | 17.5% | 13.9% | 2.2% | 25.4 |
 MS | $362B | 22.3 | 27.3 | 7.9 | 57.1% | 19.1% | 15.5% | 3.1% | 17.9 |
 JPM | $926B | 16.5 | 18.7 | 9.2 | 59.9% | 26.0% | 16.1% | 4.5% | 11.6 |
 EVR | $15B | 26.6 | 18.0 | 12.5 | 99.4% | 20.5% | 27.8% | 18.8% | 1.4 |
 LAZ | $4B | 20.1 | 11.5 | 8.1 | 31.8% | 13.0% | 27.0% | 9.5% | 5.7 |
 PJT | $4B | 23.1 | 9.2 | 7.8 | 32.4% | 21.2% | 18.9% | 20.3% | 1.1 |
 RLAY | $3B | -10.7 | — | — | 76.8% | -1971.6% | -41.1% | -37.3% | — |
 IMVT | $8B | -13.8 | — | — | — | — | -64.8% | — | — |
| Financial Services Median | — | 13.6 | 11.4 | 11.1 | 64.1% | 20.3% | 9.0% | 5.5% | 4.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 4 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
TDAC — Frequently Asked Questions
Quick answers to the most common questions about buying TDAC stock.
What is Translational Development Acquisition Corp.'s P/E ratio?
Translational Development Acquisition Corp.'s current P/E ratio is 29.1x. The historical average is 28.4x. This places it at the 100th percentile of its historical range.
What is Translational Development Acquisition Corp.'s ROE?
Translational Development Acquisition Corp.'s return on equity (ROE) is 3.7%. The historical average is 1.8%.
Is TDAC stock overvalued?
Based on historical data, Translational Development Acquisition Corp. is trading at a P/E of 29.1x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.